WATSON 761
Pill imprint WATSON 761 has been identified as Ranitidine hydrochloride 300 mg.
Ranitidine is used in the treatment of stomach ulcer; gerd; gastric ulcer maintenance treatment; indigestion; erosive esophagitis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy.
Ranitidine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Ranitidine hydrochloride Images
- Imprint:
-
WATSON 761
- Strength:
- 300 mg
- Color:
- Beige
- Size:
- 16.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- silicon dioxide colloidal
hypromellose
magnesium stearate
maltodextrin
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium bicarbonate
synthetic ferric oxide red
synthetic ferric oxide yellow
magnesium silicate
titanium dioxide
triethyl citrate
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0761
Advertisement
More Ranitidine Hydrochloride resources
- Ranitidine
- Ranitidine (Wolters Kluwer)
- Ranitidine Effervescent Tablets (Wolters Kluwer)
- Ranitidine Syrup (Wolters Kluwer)
- Ranitidine Tablets (Wolters Kluwer)
- ranitidine (Cerner Multum)
- Ranitidine Hydrochloride (AHFS DI)
- Acid Reducer Drug Facts (FDA)
- Acid Relief (FDA)
- Formucare Ranitidine (FDA)
- Good Neighbor Acid Control (FDA)
- Heartburn Relief Drug Facts (FDA)
- Leader Acid Control (FDA)
- Maximum Strength Acid Control Drug Facts (FDA)
- Ranitidine (FDA)
- Ranitidine 75 Drug Facts (FDA)
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
- Sunmark Acid Reducer Ranitidine (FDA)
- Up and Up Acid Reducer (FDA)
- Zantac Cool Mint (FDA)
- Zantac Injection (FDA)
- Ranitidine (Wolters Kluwer)
Search Again
